1477 — Ocumension Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Annual balance sheet for Ocumension Therapeutics, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	1,785	1,314	1,054	769	548
Net Total Accounts Receivable
Net Total Receivables	44.4	113	119	164	340
Total Inventory
Total Other Current Assets
Total Current Assets	1,835	1,455	1,206	979	951
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	366	448	468	452	457
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	3,331	3,044	3,271	3,974	4,091
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	216	248	315	155	257
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	223	295	351	200	410
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Total Equity	3,108	2,749	2,920	3,774	3,681
Total Liabilities & Shareholders' Equity	3,331	3,044	3,271	3,974	4,091
Total Common Shares Outstanding